Protein may be treatment target in advanced PCa

Article

Vancouver, British Columbia - Clusterin, a stress-related protein, appears to inhibit apoptosis associated with androgen withdrawal and may therefore be an important therapeutic target in men with advanced prostate cancer, say researchers from the University of British Columbia.

Recent Videos
Kyrollis Attalla, MD, an expert on prostate cancer
Kyrollis Attalla, MD, an expert on prostate cancer
Marc Bjurlin, DO, MSc, FACOS, answers a question during a Zoom video interview
Jacqueline Zillioux, MD, answers a question during a Zoom video interview
DNA molecules | Image Credit: © vitstudio - stock.adobe.com
Tony Abraham, DO, MPA, a nuclear radiologist
© 2024 MJH Life Sciences

All rights reserved.